| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021021991 |
| P356 | DOI | 10.1186/2047-783X-15-8-337 |
| P932 | PMC publication ID | 3458702 |
| P698 | PubMed publication ID | 20947470 |
| P50 | author | Andreas E. Albers | Q56953041 |
| P2093 | author name string | T L Whiteside | |
| C Bergmann | |||
| S Lang | |||
| T K Hoffmann | |||
| J Greve | |||
| E Bölke | |||
| S Brandau | |||
| S Trellakis | |||
| H Bier | |||
| M Bas | |||
| P J Schuler | |||
| S Mattheis | |||
| G Lehnerdt | |||
| P2860 | cites work | Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. | Q30591228 |
| Adaptive control methods for the dose individualisation of anticancer agents | Q33913894 | ||
| The multilayered postconfluent cell culture as a model for drug screening | Q34060933 | ||
| Pharmacokinetically guided administration of chemotherapeutic agents | Q34099816 | ||
| American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays | Q35853783 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| The roles of copper transporters in cisplatin resistance | Q36743623 | ||
| Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors | Q37017674 | ||
| The ChemoFx assay: an ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy | Q37050806 | ||
| How do real tumors become resistant to cisplatin? | Q37140435 | ||
| Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. | Q39981017 | ||
| Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors | Q40606868 | ||
| Chemotherapeutic drug resistance in the management of head and neck cancer | Q40844614 | ||
| Sigmoid model versus median-effect analysis for obtaining dose-response curves for in vitro chemosensitivity testing. | Q40955486 | ||
| Chemosensitivity testing of fresh and continuous tumor cell cultures using lactate dehydrogenase | Q41140672 | ||
| Evaluation of MTT assay in agarose for chemosensitivity testing of human cancers: comparison with MTT assay | Q41444450 | ||
| Establishment and characterization of cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79. | Q41715382 | ||
| Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. | Q42216907 | ||
| Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. | Q50787150 | ||
| Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. | Q50904345 | ||
| Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation | Q52821919 | ||
| Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. | Q53875696 | ||
| Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man | Q69687107 | ||
| Human Squamous Cell Carcinoma: Establishment and Characterization of New Permanent Cell Lines | Q70966828 | ||
| Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer | Q79368486 | ||
| A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment | Q80726091 | ||
| A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer | Q80808476 | ||
| Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations | Q83164585 | ||
| Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival | Q83367399 | ||
| P4510 | describes a project that uses | 8029 DDP4 | Q54605294 |
| 8029 NA | Q54605295 | ||
| HLaC-79 | Q54889837 | ||
| UM-SCC-10A | Q54990802 | ||
| UM-SCC-10B | Q54990803 | ||
| UM-SCC-11B | Q54990808 | ||
| UM-SCC-14A | Q54990811 | ||
| UM-SCC-14B | Q54990812 | ||
| UM-SCC-14C | Q54990813 | ||
| UM-SCC-22B | Q54990838 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | head and neck cancer | Q1783924 |
| head and neck carcinoma | Q18554836 | ||
| neck cancer | Q18966654 | ||
| cell line | Q21014462 | ||
| P304 | page(s) | 337-344 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | European Journal of Medical Research | Q5412732 |
| P1476 | title | In vitro chemosensitivity of head and neck cancer cell lines | |
| P478 | volume | 15 |
| Q35946876 | Contribution of tumoral and host solute carriers to clinical drug response |
| Q36105839 | Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients |
| Q91432481 | Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy |
| Q37373689 | Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer |
| Q38740852 | Immunomodulatory/inflammatory effects of geopropolis produced by Melipona fasciculata Smith in combination with doxorubicin on THP-1 cells |
| Q46523472 | Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio. |
| Q90481015 | Overexpression of HURP mRNA in head and neck carcinoma and association with in vitro response to vinorelbine |
| Q38692850 | Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer |
| Q36995742 | Polymorphic transporters and platinum pharmacodynamics |
| Q92661535 | Synthesis and Cytostatic Effect of 3'-deoxy-3'-C-Sulfanylmethyl Nucleoside Derivatives with d-xylo Configuration |
| Q90003730 | Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation |
| Q49787788 | The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma |
| Q36105835 | Trimodal therapy in squamous cell carcinoma of the esophagus |
Search more.